Royal Society of Chemistry, Chemical Society Reviews, 12(51), p. 5136-5174, 2022
DOI: 10.1039/d2cs00247g
Full text: Unavailable
Recent years have witnessed increasingly rapid advances in nanocarrier-based biomedicine aimed at improving treatment paradigms for cancer.